journal article·2022-12

Fabrication of PEGylated liposome in microfluidic flow process using supercritical CO2

Ryunosuke Akiyama, Yuya Murakami, Keita Inoue, Yasuhiko Orita, Yusuke Shimoyama

Journal of Nanoparticle Research· Volume 24· Issue 12
Publisher page

Abstract

Liposomes have attracted attention as appealing drug carriers in the pharmaceutical industry, which has promoted the research about the fabrication method of liposomes. In this study, microfluidic flow process using supercritical carbon dioxide (scCO2) was applied to the fabrication of PEGylated liposomes. We investigated the effect of PEG-lipid concentration on the liposome properties such as size distribution, encapsulation efficiency, and fixed aqueous layer thickness, while the supplying line of PEG-lipid was varied. As a result, microfluidic process using scCO2 gave the PEGylated liposome with narrower size distribution and higher encapsulation efficiency than those from the thin layer method. In addition, a fixed aqueous layer thickness could be successfully controlled by changing the PEG-lipid concentration. These results suggest that microfluidic process using scCO2 can be a promising technique to fabricate the PEGylated liposome with controllable size and PEGylation state. Graphical Abstract
Source: expertdata · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Phase Equilibria and Thermodynamics · Innovative Microfluidic and Catalytic Techniques Innovation · Microfluidic and Capillary Electrophoresis Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (25)

Show source-provided references
1. Allen TM, Cullis PR (2004) Drug delivery systems: entering the mainstream. Sci 303:1818–1822. https://doi.org/10.1126/science.109583310.1126/science.1095833 ↗
2. Kaialy W, Shafiee MA (2016) Recent advances in the engineering of nanosized active pharmaceutical ingredients: promises and challenges. Adv Colloid Interf Sci 228:71–91. https://doi.org/10.1016/j.cis.2015.11.01010.1016/j.cis.2015.11.010 ↗
3. Iqbal MA et al (2012) Nanostructured lipid carriers system: recent advances in drug delivery. J Drug Target 20:813–830. https://doi.org/10.3109/1061186x.2012.71684510.3109/1061186x.2012.716845 ↗
4. Blagden N et al (2007) Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates. Adv Drug Deliv Rev 59:617–630. https://doi.org/10.1016/j.addr.2007.05.01110.1016/j.addr.2007.05.011 ↗
5. Bangham AD et al (1965) Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 13:238–252. https://doi.org/10.1016/S0022-2836(65)80093-610.1016/S0022-2836(65)80093-6 ↗
6. Bangham AD et al (1967) Osmotic properties and water permeability of phospholipid liquid crystals. Chem Phys Lipids 1:225–246. https://doi.org/10.1016/0009-3084(67)90030-810.1016/0009-3084(67)90030-8 ↗
7. Papahadjopoulos D, Miller N (1967) Phospholipid model membranes. I. Structural characteristics of hydrated liquid crystals. Biochim Biophys Acta 135:624–638. https://doi.org/10.1016/0005-2736(67)90094-610.1016/0005-2736(67)90094-6 ↗
8. Kagawa Y, Racker E (1971) Partial resolution of the enzymes catalyzing oxidative phosphorylation. J Biol Chem 246:5477–5487. https://doi.org/10.1016/S0021-9258(18)61930-110.1016/S0021-9258(18)61930-1 ↗
9. Batzri S, Korn ED (1973) Single bilayer liposomes prepared without sonication. Biochim Biophys Acta 298:1015–1019. https://doi.org/10.1016/0005-2736(73)90408-210.1016/0005-2736(73)90408-2 ↗
10. Deamer D, Bangham AD (1976) Large volume liposomes by an ether vaporization method. Biochimi Biophys Acta 443:629–634. https://doi.org/10.1016/0005-2736(76)90483-110.1016/0005-2736(76)90483-1 ↗
11. Szoka FJ, Papahadjopoulos D (1978) Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc Natl Acad Sci 75:4194–4198. https://doi.org/10.1073/pnas.75.9.419410.1073/pnas.75.9.4194 ↗
12. Jung J, Perrut M (2001) Particle design using supercritical fluids: literature and patent survey. J Supercrit Fluids 20:179–219. https://doi.org/10.1016/S0896-8446(01)00064-X10.1016/S0896-8446(01)00064-X ↗
13. Ding L et al (2020) Changes in protein structure and physicochemical properties of egg white by super critical carbon dioxide treatment. J Food Eng 284:110076. https://doi.org/10.1016/j.jfoodeng.2020.11007610.1016/j.jfoodeng.2020.110076 ↗
14. Otake K et al (2001) Development of a new preparation method of liposomes using supercritical carbon dioxide. Langmuir 17:3898–3901. https://doi.org/10.1021/la010122k10.1021/la010122k ↗
15. Sakai H et al (2008) Preparation and properties of liposomes composed of various phospholipids with different hydrophobic chains using a supercritical reverse phase evaporation method. J Oleo Sci 57(11):613–621. https://doi.org/10.5650/jos.57.61310.5650/jos.57.613 ↗
16. Aburai K et al (2011) Preparation of liposome modified with lipopeptides using a supercritical carbon dioxide reverse-phase evaporation method. J Oleo Sci 60(5):209–215. https://doi.org/10.5650/jos.60.20910.5650/jos.60.209 ↗
17. Otake K et al (2006) Preparation of liposomes using an improved supercritical reverse phase evaporation method. Langmuir 22:2543–2550. https://doi.org/10.1021/la051654u10.1021/la051654u ↗
18. Murakami Y et al (2022) LipTube: liposome formation in the tube process using supercritical CO2. Ind Eng Chem Res 61:14598–14608. https://doi.org/10.1021/acs.iecr.2c0209510.1021/acs.iecr.2c02095 ↗
19. Shimada K et al (1995) Determination of the thickness of the fixed aqueous layer around the polyethyleneglycol-coated liposomes. J Drug Target 3:283–292. https://doi.org/10.3109/1061186950901595710.3109/10611869509015957 ↗
20. Immordino M et al (2006) Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomed 1(3):297–31510.2217/17435889.1.3.297 ↗
21. Israelachivili JN (1985) Intermolecular and surface force. Academic Press, London
22. Sadzuka Y et al (2002) Effects of mixed polyethyleneglycol modification on fixed aqueous layer thickness antitumor activity of doxorubicin containing liposome. Int J Pharm 234:171–180. https://doi.org/10.1016/s0378-5173(02)00075-310.1016/s0378-5173(02)00075-3 ↗
23. Fendler JH et al (1994) The colloidal domain: where physics, chemistry, biology, and technology meet. In: D. Fennell Evans and HakånWennerström. VCH Publishers, New York. https://doi.org/10.1002/adma.1996008031810.1002/adma.19960080318 ↗
24. Alinaghi A et al (2014) The influence of lipid composition and surface charge on biodistribution of intact liposomes releasing from hydrogel-embedded vesicles. Int J Pharm 459(1–2):30–39. https://doi.org/10.1016/j.ijpharm.2013.11.01110.1016/j.ijpharm.2013.11.011 ↗
25. Deng H et al (2015) Reactive oxygen species (ROS) responsive PEG–PCL nanoparticles with pH-controlled negative-to-positive charge reversal for intracellular delivery of doxorubicin. J Mater Chem B 3(48):9397–9408. https://doi.org/10.1039/C5TB01939G10.1039/C5TB01939G ↗